Multi Barrier Reverse Convertible

Symbol: KZOWDU
ISIN: CH1428232214
Issuer:
UBS
Trade

Chart

    
    

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Price Time-delayed price
24.08.26
14:17:08
99.65 %
100.70 %
CHF
Volume
100,000
100,000
nominal
Trading hours for this product: 9:15 – 17:15

Performance

Closing prev. day 99.75
Diff. absolute / % -0.30 -0.30%

Determined prices

Last Price 96.90 Volume 25,000
Time 11:55:53 Date 20/07/2026

More Product Information

Core Data

Name Multi Barrier Reverse Convertible
ISIN CH1428232214
Valor 142823221
Symbol KZOWDU
Quotation in percent Yes
Coupon p.a. 8.50%
Coupon Premium 8.12%
Coupon Yield 0.38%
Type Multi Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached No
Exercise type American
Currency Swiss Franc
First Trading Date 26/03/2025
Date of maturity 28/09/2026
Last trading day 21/09/2026
Settlement Type Cash payout
IRS 871m Not applicable
Currency safeguarded Yes
Pricing Clean
Issuer UBS

Key data

Ask Price (basis for calculation) 100.5000
Maximum yield 0.31%
Maximum yield p.a. 3.22%
Sideways yield 0.31%
Sideways yield p.a. 3.22%

market maker quality Date: 21/08/2026

Average Spread 1.01%
Last Best Bid Price 99.75 %
Last Best Ask Price 100.80 %
Last Best Bid Volume 100,000
Last Best Ask Volume 100,000
Average Buy Volume 100,000
Average Sell Volume 100,000
Average Buy Value 99,252 CHF
Average Sell Value 100,256 CHF
Spreads Availability Ratio 99.60%
Quote Availability 99.60%

Underlyings

Name Sanofi S.A. Bayer AG Roche PS
ISIN FR0000120578 DE000BAY0017 CH1499059983
Price 71.8000 CHF 45.57 CHF 370.4000 CHF
Date 17/08/26 11:48 17/08/26 09:01 24/08/26 14:17
Cap 107.98 EUR 24.39 EUR 306.0000 CHF
Distance to Cap -29.04 23.3 65.1
Distance to Cap in % -36.79% 48.86% 17.54%
Is Cap Level reached No No No
Barrier 64.79 EUR 14.63 EUR 183.60 CHF
Distance to Barrier 14.15 33.06 187.5
Distance to Barrier in % 17.93% 69.32% 50.53%
Is Barrier reached No No No

Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.